Okada Y, Yanagisawa T, Taira N
Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):438-44. doi: 10.1007/BF00165396.
Potassium (K+) channel openers decrease intracellular free Ca2+ concentrations ([Ca2+]i by hyperpolarizing the membrane and deactivating the Ca(2+)-channels. To examine whether the hyperpolarization produced by K(+)-channel openers has other effects on the mechanical activity of vascular smooth muscle, we investigated the effects of levcromakalim (BRL 38227) on membrane potential, [Ca2+]i, as measured with fura-2, and force of contraction induced by 30 mmol/l KCl-physiological salt solution (PSS), in canine coronary arteries. BRL 38227 hyperpolarized the membrane and reduced increases in [Ca2+]i and in contractile force induced by 30 mmol/l KCl-PSS. The [Ca2+]i-contractile force curve, determined in the presence of BRL 38227, was located to the right of the control curve determined by decreasing extracellular Ca2+ concentrations ([Ca2+]o) in 30 mmol/l KCl-PSS. The [Ca2+]i-contractile force curve, determined by decreasing extracellular K+ concentrations ([K+]o), was also located to the right of that determined by decreasing [Ca2+]o in 30 mmol/l KCl-PSS. The effect of BRL 38227, a reduction in the Ca(2+)-sensitivity of contractile elements, was antagonized by the ATP-sensitive K(+)-channel blocker, glibenclamide (10(-6) or 10(-5) mol/l). These results suggest that the membrane hyperpolarization induced by BRL 38227, or the repolarization caused by reducing [K+]o, decreases the Ca(2+)-sensitivity of contractile elements of vascular smooth muscle.
钾(K+)通道开放剂通过使细胞膜超极化并使钙(Ca2+)通道失活来降低细胞内游离钙浓度([Ca2+]i)。为了研究K+通道开放剂产生的超极化是否对血管平滑肌的机械活性有其他影响,我们研究了左卡尼汀(BRL 38227)对犬冠状动脉膜电位、用fura-2测量的[Ca2+]i以及由30 mmol/l氯化钾-生理盐溶液(PSS)诱导的收缩力的影响。BRL 38227使细胞膜超极化,并减少了30 mmol/l KCl-PSS诱导的[Ca2+]i和收缩力的增加。在BRL 38227存在下测定的[Ca2+]i-收缩力曲线位于通过降低30 mmol/l KCl-PSS中的细胞外钙浓度([Ca2+]o)测定的对照曲线的右侧。通过降低细胞外钾浓度([K+]o)测定的[Ca2+]i-收缩力曲线也位于通过降低30 mmol/l KCl-PSS中的[Ca2+]o测定的曲线的右侧。ATP敏感性K+通道阻滞剂格列本脲(10(-6)或10(-5) mol/l)拮抗了BRL 38227降低收缩元件钙(Ca2+)敏感性的作用。这些结果表明,BRL 38227诱导的细胞膜超极化或降低[K+]o引起的复极化降低了血管平滑肌收缩元件的钙(Ca2+)敏感性。